|
Canada-0-CARDBOARD BOXES ไดเรกทอรีที่ บริษัท
|
ข่าว บริษัท :
- Ultima Genomics | High-Throughput, Cost-Effective DNA Sequencing Solutions
Ultima Genomics sequencing platforms include a dedicated high-performance server that can robustly perform read and sample-level bioinformatics without impacting sequencing throughput
- Ultima Genomics - Wikipedia
Ultima Genomics Ultima Genomics, Inc is an American biotechnology company that develops and manufactures systems for high-throughput DNA sequencing
- Ultima Genomics Introduces the Next Generation of Sequencing at Scale . . .
Ultima Genomics is unleashing the power of genomics at scale The Company's mission is to continuously drive the scale of genomic information to enable unprecedented advances in biology and improvements in human health
- Ultima Genomics Announces UG200 Series Selected for Basecamp Researchs . . .
Ultima Genomics is unleashing the power of genomics at scale The Company's mission is to continuously drive the scale of genomic information to enable unprecedented advances in biology and
- The Ultima Genomics UG 100: Challenging Illuminas Dominance in High . . .
A deep dive into the Ultima Genomics UG 100 platform and comparison with similar offerings from Illumina
- Ultima Genomics - LinkedIn
Ultima Genomics is unleashing the power of genomics at scale Our mission is to continuously drive the scale of genomic information to enable unprecedented advances in biology and improvements
- Ultima Genomics UG 100 platform vs. Illumina NovaSeq X Series whole . . .
In 2024, Ultima Genomics launched the UG 100 sequencing platform with bold performance and accuracy claims To evaluate these claims, Illumina conducted a comparative analysis of the NovaSeq X Series and the UG 100 platform This article details the results of the analysis
- From Cost to Compute: What Ultima and NVIDIA Reveal About the Future of . . .
From Cost to Compute: What Ultima and NVIDIA Reveal About the Future of Sequencing At GTC 2026, a presentation from Gilad Almogy highlighted an industry shift from cost-constrained to scale-driven genomics, reshaping clinical diagnostics, biobanks, and next-generation drug discovery
- Automated Workflows Aim To Scale Genomics Research
Ultima Genomics, announced a partnership to automate Ultima’s latest sample preparation and amplification technology across Hamilton's Microlab® STAR™ liquid handling platform The collaboration enables scalable, efficient next-generation sequencing (NGS) workflows with a simplified user
- Abstract 3863: Enhanced cfDNA fragmentation-based treatment monitoring . . .
AbstractIntroduction: Whole-genome analysis of cell-free DNA (cfDNA) fragmentation, such as DELFI-Tumor Fraction (DELFI-TF), has emerged as a powerful tool for monitoring therapeutic response in patients with late-stage cancer In this study, we assessed the technical feasibility of the Ultima Genomics sequencing platform for a cfDNA fragmentation-based monitoring application Methods: The
|
|